NDC 59746-385 – Terazosin

Terazosin Hydrochloride 5 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC59746-385

Product details

Brand name
Terazosin
Generic name
Terazosin Hydrochloride
Labeler
Jubilant Cadista Pharmaceuticals Inc.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075317
Marketed since
December 20, 2004
Listing expires
December 31, 2027
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (4)

Package NDCDescriptionSince
59746-385-06100 CAPSULE in 1 BOTTLE (59746-385-06)Dec 20, 2004
59746-385-09500 CAPSULE in 1 BOTTLE (59746-385-09)Dec 20, 2004
59746-385-101000 CAPSULE in 1 BOTTLE (59746-385-10)Dec 20, 2004
59746-385-9090 CAPSULE in 1 BOTTLE (59746-385-90)Dec 20, 2004

Other Terazosin products